Alpha Cognition is trading 7.35% higher at $8.91 in pre-market; an October 27 update attributed the prior-session rise to broader biotech-sector strength.
- The update reported that XBI gained 2.18%.
- No new company-specific announcement was reported, and no October 28 announcement was found in the available results.
- Recent company news concerned presentations planned for later dates, not a newly announced catalyst.